• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Personnel Moves

Tandem Diabetes Care appoints Dr. Jordan Pinsker as its medical director

March 1, 2021 By Sean Whooley

Tandem Diabetes Care

Tandem Diabetes Care (NSDQ:TNDM) announced today that it appointed Dr. Jordan Pinsker as its VP & medical director. The San Diego-based insulin delivery technology developer’s appointment of Pinsker will be made effective on April 26, 2021, according to a news release. Pinsker joins Tandem from Sansum Diabetes Research Institute in Santa Barbara, Calif., where he served […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured Tagged With: Personnel, Personnel Moves, Tandem Diabetes Care

B. Braun Medical appoints new CFO

February 23, 2021 By Sean Whooley

B. Braun Medical announced today that it appointed James Allen as a senior VP and as the company’s chief financial officer. Allen, a veteran of more than 30 years in finance and management within multiple industries and disciplines, will replace Bruce Heugel, who last year announced that he would retire after more than 20 years at […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pain Management Tagged With: B. Braun Medical, Personnel, Personnel Moves

Re-Vana Therapeutics appoints new COO, VP of R&D

February 23, 2021 By Sean Whooley

Re-Vana Therapeutics announced today that it appointed Michael Nash as chief commercial officer and David Shima as VP of R&D. Belfast, Northern Ireland-based Re-Vana’s two new executives are set to help the company develop its sustained-release therapies for ophthalmic indications, including neovascular age-related macular degeneration (wet AMD), diabetic retinopathy (DR) and glaucoma, according to a […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Optical/Ophthalmic, Pharmaceuticals Tagged With: Personnel, Personnel Moves, Re-Vana Therapeutics

Acorda Therapeutics announces departure of business operations chief

February 19, 2021 By Sean Whooley

Acorda Therapeutics (NSDQ:ACOR) announced today that its chief of business operations, David Lawrence, is resigning from the company. Lawrence, who also serves as Acorda’s principal accounting and financial officer, is resigning effective mid-March 2021 as he is set to take a leadership position at an early-stage biotechnology company, according to a news release. “Dave has […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Neurological, Pharmaceuticals Tagged With: Acorda Therapeutics, Personnel, Personnel Moves

Lyra Therapeutics names new chief medical officer

February 17, 2021 By Sean Whooley

Lyra Therapeutics (NSDQ:LYRA) announced today that it appointed Dr. Robert Kern as its new chief medical officer. Kern will remain in his current position as the George A. Sisson Professor and Chair, Department of Otolaryngology – Head and Neck Surgery at the Northwestern University Feinberg School of Medicine while operating as Lyra’s CMO, according to […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Otolaryngology Ear, Nose & Throat, Pharmaceuticals Tagged With: Lyra Therapeutics, Personnel Moves

Dyve Biosciences appoints Camilla V. Simpson to its board

February 3, 2021 By Sean Whooley

Dyve Bioscience logo

Clinical-stage biotechnology company Dyve Biosciences announced this week that Camilla V. Simpson joined its board of directors. Simpson possesses over 25 years of experience in the biotech industry, currently serving as an independent member of the board of directors at Spruce Biosciences and as a member of the scientific advisory board at Aristea Therapeutics, according […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pain Management Tagged With: dyvebioscience, Personnel Moves

Bigfoot Biomedical appoints commercial team

December 9, 2020 By Sean Whooley

Bigfoot Biomedical updated logo

Bigfoot Biomedical announced today that it established a team led by Berkley Nelson to lead the company’s sales effort. Bigfoot is marketing its the recently FDA-cleared Bigfoot Unity real-time, dose-decision support system, which uses smartpen caps and integrates Abbott’s FreeStyle Libre 2 continuous glucose monitoring platform. Get the full story at our sister site, MassDevice.

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured Tagged With: Bigfoot Biomedical, Personnel, Personnel Moves

Delcath names new CEO

October 2, 2020 By Sean Whooley

delcath-systems

Delcath Systems (OTC:DCTH) announced that it appointed Gerard Michel as its new CEO, effective yesterday, Oct. 1, 2020. Michel assumed the role yesterday and also was appointed as a Class I director on the company’s board of directors, with that role continuing until the expiry of his term at the company’s 2022 annual meeting of stockholders, […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Oncology Tagged With: Delcath Systems Inc., Personnel Moves

Monarch Medical Technologies appoints diabetes tech veteran as new CEO

August 7, 2020 By Sean Whooley

Monarch Medical Technologies announced that it appointed industry veteran Raymie McFarland as its new president & CEO. As McFarland takes over day-to-day management, Brian Duffy and Christophe Mallard, two of the Charlotte, N.C.-based diabetes technology company’s board members, will relinquish their respective roles as interim CEO and interim president. McFarland spent the previous nine years […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations Tagged With: Monarch Medical Technologies, Personnel Moves

Former Eli Lilly researcher joins Bigfoot Biomedical as chief medical officer

June 12, 2020 By Chris Newmarker

Bigfoot Biomedical updated logo

Bigfoot Biomedical has brought on Dr. Jim Malone — a 21-year clinical research veteran at Eli Lilly & Co. — as its chief medical officer, the diabetes treatment tech company said today. Malone, an endocrinologist specializing in diabetes, also spent 12 years in clinical practice. “Jim’s blended experience in medical practice and device development bring […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured Tagged With: Bigfoot Biomedical, Personnel Moves

  • « Go to Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Go to page 6
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS